MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from ...
The FINANCIAL — PRP is delighted to announce the award of a significant manufacturing contract from the Eastman Kodak Company. The contract to manufacture 1200dpi LED print heads is the culmination of ...
Platelet-rich plasma (PRP) therapy is a controversial treatment that uses a concentrated form of a person’s platelets to promote healing and regeneration in various tissues. PRP is becoming ...
Novel Proenzyme Pharmaceutical Formulation to be Administered by Intravenous (I.V.) Injection in World First, Phase I First-In-Human Study in Advanced Cancer Patients Propanc Biopharma, Inc. (OTCQB: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback